Advertisement

Topics

Genervon Biopharmaceuticals LLC Company Profile

07:53 EDT 24th September 2018 | BioPortfolio

Genervon is a privately funded clinical stage biopharmaceutical company in California developing breakthrough multi-target bio-drugs to address the world’s critical unmet medical needs.


News Articles [199 Associated News Articles listed on BioPortfolio]

Genervon Biopharmaceuticals poised to find Big Pharma partner to commercialize its GM6 drug

Genervon Biopharmaceuticals CEO Winston Ko tells Proactive Investors he's fresh off of a speaking engagement at the American Society of Experimental Neurotherapeutics, where he explained how Genervo...

Genervon inviting partnership for commercialization

Founder & Chairman Winston Ko from Genervon Biopharmaceuticals tells Proactive Investors they are looking to partner with pharmaceutical companies for commercialization. Ko says Genervon had ...

Genervon consultant to present novel method to test peptide drugs at PhysChem Forum

Genervon Biopharmaceuticals COO Dorothy Ko tells Proactive Investors the company is gearing up for the PhysChem Forum in Basel, Switzerland, on April 17. Ko says there has been a lack of methodolo...

Transgene and Tasly Biopharmaceuticals Conclude Strategic Agreements for the Rights of Transgene's Virus-Based Immunotherapies TG6002 and TG1050 in Greater China

Transgene to receive $48 million paid in newly created Tasly Biopharmaceuticals shares Deals give Tasly Biopharmaceuticals full control over Greater China1 development and commercial rights to the...

Akebia Therapeutics to merge with Keryx Biopharmaceuticals

US-based biopharmaceutical firm Akebia Therapeutics has signed a definitive agreement to merge with Keryx Biopharmaceuticals to form a fully integrated...Read More... The post Akebia Therapeutics to m...

Eiger BioPharmaceuticals completes enrolment in Prevent trial

Eiger BioPharmaceuticals has completed patient enrolment in the Phase ll Prevent trial evaluating the safety and durability of subcutaneous (SC)...Read More... The post Eiger BioPharmaceuticals comple...

5 Top Weekly NASDAQ Biotech Stocks: Eiger BioPharmaceuticals Leads with 81.62 Percent

Eiger BioPharmaceuticals, Arqule, Galectin Therapeutics, MEI Pharma and BioDelivery Sciences were last week's top gainers on the NASDAQ. The post 5 Top Weekly NASDAQ Biotech Stocks: Eiger BioPharmace...

Alder BioPharmaceuticals, Inc. (ALDR) to Present at the Canaccord Genuity 38th Annual Growth Conference

Alder BioPharmaceuticals® to Present at the Canaccord Genuity 38th Annual Growth Conference Alder BioPharmaceuticals, Inc. (ALDR), a biopharmaceutical company focused on developing novel therapeutic ...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Thrombin human [Ethicon, Inc]

These highlights do not include all the information needed to use EVITHROM safely and effectively. See full prescribing information for EVITHROM.EVITHROM, Thrombin, Topical (Human)For Topical Use Only...

PubMed Articles [39 Associated PubMed Articles listed on BioPortfolio]

Surfactants as Stabilizers for Biopharmaceuticals: An Insight into the Molecular Mechanisms for Inhibition of Protein Aggregation.

Surfactants are common stabilizers, often added to biopharmaceuticals formulations, but the mechanisms at the basis of their activity are unclear. The aim of this work is to provide insight into the m...

Next Generation Biopharmaceuticals: Product Development.

Therapeutic proteins show a rapid market growth. The relatively young biotech industry already represents 20 % of the total global pharma market. The biotech industry environment has traditionally bee...

Characterisation of protein aggregation with the Smoluchowski coagulation approach for use in biopharmaceuticals.

Protein aggregation is a field of increasing importance in the biopharmaceutical industry. Aggregated particles decrease the effectiveness of the drug and are associated with other risks, such as incr...

Development and validation of a bioassay to evaluate binding of adalimumab to cell membrane-anchored TNFα using flow cytometry detection.

Physicochemical and structural properties of proteins used as active pharmaceutical ingredients of biopharmaceuticals are determinant to carry out their biological activity. In this regard, the assays...

Harnessing the power of an expanded genetic code toward next-generation biopharmaceuticals.

Synthetic biology has been revolutionizing the biopharmaceutical industry from drug discovery, clinical development to the manufacturing of biopharmaceuticals. As one of its most promising areas, gene...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Nicotine Vaccination and Nicotinic Receptor Occupancy

This is a molecular imaging research study designed to examine how much nicotine gets into the brain before and after vaccination with NicVAX, a nicotine vaccine developed by Nabi Biopharm...

A Phase III Clinical Trial of a Haemophilus Influenzae Type b (Hib) Conjugate Vaccine

Haemophilus influenza type b (Hib) remains a serious global health threat associated with high mortality and morbidity in young children. In China, The overall impact of Hib-related infect...

Companies [186 Associated Companies listed on BioPortfolio]

Genervon Biopharmaceuticals, LLC

Genervon has discovered a novel endogenous embryonic stage family of 9 human Master Regulators of the Nervous System. It has obtained 46 Composition of Matter and Use patents. ...

Genervon Biopharmaceuticals LLC

Genervon is a privately funded clinical stage biopharmaceutical company in California developing breakthrough multi-target bio-drugs to address the world’s critical unmet ...

Itero Biopharmaceuticals, Inc.

Itero Biopharmaceuticals, Inc. is a specialty biopharmaceutical company focused on the development and commercialization of protein therapeutics that offer significant clinical an...

Bechtel Group Biopharmaceuticals Production

Design, construction, and validation of facilities for production of human biopharmaceuticals utilizing either fermentation or cell culture, facilities maintenance & operation for the virtual organiza...

BioRexis Pharmaceutical Corporation

BioRexis™ develops and produces novel biopharmaceuticals with superior pharmacology using efficient manufacturing systems. Many biopharmaceuticals face difficulties in development and commercializat...

More Information about "Genervon Biopharmaceuticals LLC" on BioPortfolio

We have published hundreds of Genervon Biopharmaceuticals LLC news stories on BioPortfolio along with dozens of Genervon Biopharmaceuticals LLC Clinical Trials and PubMed Articles about Genervon Biopharmaceuticals LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genervon Biopharmaceuticals LLC Companies in our database. You can also find out about relevant Genervon Biopharmaceuticals LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record